| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/23/2023 | 3.11% | Barclays | $95 → $67 | Maintains | Equal-Weight |
| 07/20/2023 | 46.2% | Barclays | → $95 | Initiates Coverage On | → Equal-Weight |
| 07/07/2023 | 66.2% | Craig-Hallum | $88 → $108 | Maintains | Buy |
| 07/07/2023 | 53.89% | Benchmark | $76 → $100 | Maintains | Buy |
| 07/07/2023 | 30.81% | Stephens & Co. | → $85 | Reiterates | Overweight → Overweight |
| 06/02/2023 | 35.43% | Citigroup | → $88 | Initiates Coverage On | → Neutral |
| 04/26/2023 | 0.03% | Lake Street | → $65 | Initiates Coverage On | → Hold |
| 04/05/2023 | 35.43% | Craig-Hallum | $70 → $88 | Maintains | Buy |
| 04/05/2023 | 38.5% | Roth MKM | $65 → $90 | Maintains | Buy |
| 04/05/2023 | 16.96% | Benchmark | $70 → $76 | Maintains | Buy |
| 02/15/2023 | 7.73% | Benchmark | → $70 | Initiates Coverage On | → Buy |
| 01/13/2023 | 30.81% | Stephens & Co. | → $85 | Reiterates | → Overweight |
| 01/06/2023 | -18.44% | BMO Capital | $70 → $53 | Maintains | Market Perform |
| 09/23/2022 | 30.81% | Stephens & Co. | → $85 | Initiates Coverage On | → Overweight |
| 07/11/2022 | 23.11% | BMO Capital | → $80 | Downgrades | Outperform → Market Perform |
| 07/08/2022 | 30.81% | Craig-Hallum | $84 → $85 | Maintains | Buy |
| 11/15/2021 | 10.8% | Stephens & Co. | $62 → $72 | Maintains | Overweight |
| 08/02/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/14/2021 | -29.21% | Roth Capital | $38 → $46 | Maintains | Buy |
| 05/10/2021 | -35.36% | BMO Capital | $35 → $42 | Maintains | Outperform |
| 04/14/2021 | -41.52% | Roth Capital | $30 → $38 | Reiterates | → Buy |
| 01/26/2021 | -56.91% | Stephens & Co. | $24 → $28 | Maintains | Overweight |
| 01/12/2021 | -61.53% | Craig-Hallum | $17 → $25 | Upgrades | Hold → Buy |
| 01/12/2021 | -66.14% | Roth Capital | $21 → $22 | Maintains | Buy |
| 01/07/2021 | -63.07% | Stephens & Co. | $20 → $24 | Maintains | Overweight |
| 11/17/2020 | -69.22% | Stephens & Co. | $16 → $20 | Maintains | Overweight |
| 11/17/2020 | -67.68% | Roth Capital | $17 → $21 | Maintains | Buy |
| 07/10/2020 | -75.38% | Craig-Hallum | $25 → $16 | Downgrades | Buy → Hold |
| 04/15/2020 | -67.68% | BMO Capital | $30 → $21 | Maintains | Outperform |
| 09/09/2019 | -49.22% | Maxim Group | → $33 | Initiates Coverage On | → Buy |
| 08/26/2019 | -53.83% | BTIG | → $30 | Initiates Coverage On | → Buy |
| 08/26/2019 | -53.83% | Stephens & Co. | → $30 | Initiates Coverage On | → Overweight |
| 08/26/2019 | -53.83% | BMO Capital | → $30 | Initiates Coverage On | → Outperform |
What is the target price for Kura Sushi USA (KRUS)?
The latest price target for Kura Sushi USA (NASDAQ: KRUS) was reported by Barclays on October 23, 2023. The analyst firm set a price target for $67.00 expecting KRUS to rise to within 12 months (a possible 3.11% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kura Sushi USA (KRUS)?
The latest analyst rating for Kura Sushi USA (NASDAQ: KRUS) was provided by Barclays, and Kura Sushi USA maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Kura Sushi USA (KRUS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kura Sushi USA, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kura Sushi USA was filed on October 23, 2023 so you should expect the next rating to be made available sometime around October 23, 2024.
Is the Analyst Rating Kura Sushi USA (KRUS) correct?
While ratings are subjective and will change, the latest Kura Sushi USA (KRUS) rating was a maintained with a price target of $95.00 to $67.00. The current price Kura Sushi USA (KRUS) is trading at is $64.98, which is out of the analyst's predicted range.